MARKET

SAVAW

Cassava Sciences, Inc. Warrants
SAVAW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-
-
0.0092
-
CASSAVA SCIENCES INC: WILL PAY $31.25 MLN FOR COMPLETE SETTLEMENT AND RELEASE OF ALL CLAIMS
Reuters · 12/23/2025 13:00
CASSAVA ANNOUNCES AGREEMENT TO SETTLE SECURITIES CLASS ACTION LITIGATION
Reuters · 12/23/2025 13:00
CASSAVA SCIENCES: TO RESOLVE LITIGATION FILED IN US DISTRICT COURT IN TEXAS
Reuters · 12/23/2025 13:00
Cassava Sciences Settles Securities Class Action for $31.25 Million
Reuters · 12/23/2025 13:00
Cassava Sciences Names Dawn C. Bir to Compensation Committee
Reuters · 12/22/2025 21:10
CASSAVA SCIENCES INC - ON DEC 15, FDA PLACES FULL CLINICAL HOLD ON CASSAVA'S TRIAL - SEC FILING
Reuters · 12/18/2025 22:04
CASSAVA SCIENCES: NOT EXPECTED TO INITIATE PROOF-OF-CONCEPT CLINICAL TRIAL FOR SIMUFILAM IN TSC-RELATED EPILEPSY IN H1 2026 AS PREVIOUSLY DISCLOSED
Reuters · 12/18/2025 22:04
FDA Puts Cassava Sciences Simufilam Trial on Full Clinical Hold
Reuters · 12/18/2025 22:03
More

Webull offers Cassava Sciences, Inc. Warrants stock information, including NASDAQ: SAVAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SAVAW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SAVAW stock methods without spending real money on the virtual paper trading platform.